Watch Demo

Global ADME-Toxicology Testing Industry

Global ADME-Toxicology Testing Industry

  • Publish Date:January 2023

  • Number of Pages:472

  • Report ID:1375382

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 5600

Summary

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global ADME-Toxicology Testing Market to Reach $17.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$7.7 Billion in the year 2022, is projected to reach a revised size of US$17.3 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030. Cell Culture, one of the segments analyzed in the report, is projected to record a 12.6% CAGR and reach US$8.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 14% CAGR

The ADME-Toxicology Testing market in the U.S. is estimated at US$3.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 11.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Select Competitors (Total 79 Featured)
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- BioreclamationIVT, LLC
- CompuDrug International, Inc.
- Cyprotex PLC.
- Eurofins ADME BIOANALYSES SAS
- Molecular Discovery Ltd.
- MultiCASE, Inc.
- PerkinElmer, Inc.
- Pharmaron, Inc.
- Promega Corporation
- Simulations Plus, Inc.
- Taconic Biosciences, Inc.
- Takara Bio Europe AB
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
ADME-Toxicology Testing - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
ADME-Tox : An Introduction
A Prelude to ADME Toxicology Testing
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET
Global Market Prospects and Growth Drivers
Drug Makers Bet on ADME & Toxicology Testing to Improve Success
Rate for Potential Drug Candidates
Cell Culture Holds a Major Share of the Market
North America and Europe Dominate, Asia-Pacific Witnesses Rapid
Growth
Competition
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Increased Need to Check Late-Stage Drug Failures Drive Market
Growth
Steady Increase in Average Drug Development Cost and Efforts to
Mitigate Late-Stage Drug Failure Rates Highlights the Role of
ADME-Toxicology Testing: Average Cost of Drug Development
(in US$ Billion) in the US since 1980s
Impact of ADME-Tox Screening on New Drug Discovery
Table 1: Phase-I Clinical Trial Failures Before and After the
Advent of Preclinical ADME/Pharmacokinetics
actors Leading to Failure of Drugs in Phase III Clinical
Trials: Percentage Breakdown of Number of Cases for Efficacy,
Pharmacokinetics, Toxicity and Others
Drug Withdrawals Due to Toxicity Issues (1990-early 2010s):
Percentage Share Breakdown of Number of Drugs Withdrawn Due to
Cardiotoxicity, Hepatotoxicity and Others
Pharma Industry Renews Focus on Cost Optimization
Global Pharmaceutical R&D Spending (US$ Billion) for the Years
2011 through 2020
New FDA Approvals (2010-2020): Breakdown of Number of Approvals
by Type for New Molecular Entity (NME) and Biologic License
Application (BLA) Approvals
China and India: Hot Spots for R&D Investment
World R&D Market by Geographic Region (2020): Percentage
Breakdown of R&D Spending for Asia, Europe, Middle East &
Africa, North America and South America
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro
Technologies to Lead the Charge
Growing Prominence of Cell-based Assays in Drug Discovery and
ADME Analysis
Global Cell-based Assays Market by Segment (2020): Percentage
Share Breakdown of Value Sales for Consumables, Instruments,
Software, and Services
Global Market for Cell-based Assays by End-User (2020):
Percentage Share Breakdown of Value Sales for Pharma & Biotech
Companies, Government & Academic Institutes, CROs, and Others
World Cell-based Assays Market by Application (2020):
Percentage Breakdown of Revenue for ADME, Basic Research and
Drug Discovery
Major Types of Cell-Based HTS Assays for Drug Screening
Cell-based Assays in HTS and UHTS
Innovation in Screening Guarantees Success for Drug Discovery
Programs
High-Content Screening (HCS) - An Expanding Technology in Cell-
Based Assays
High Content Screening - Key Application Areas
HCS Market Ripe with Growth Opportunity
HCS vs. HTS
Increasing Use of Cell-Based Assays over Other Methods in
Toxicity Testing
3D Cell Culture Technology to Put a New Spin on In Vitro Cell
Analyses
CDER's DARS 2?Microphysiological 3D Cell Culture Platforms as
Drug Development Tools
Rising Investment in Proteomics R&D Drive Cell-based Assays Market
Automated Multiplexing Platforms Present Growth Opportunities
Automation of Cell-based Assays: A Growing Trend
In-Silico ADME Emerge as Compelling Drug Discovery &
Development Tool
Advantages of Using In Silico Approaches
Personalized Treatments & Computational Tools: Intriguing
Facets of ADME R&D ADME Pharmacogenomics to Power Personalized
Treatments
ADME Research & Emerging Computational Tools
Omics Technology
Adoption of Omics-based Technologies
In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs
Limitations of Traditional in vitro Cellular Models
Organoids Technology?Advanced in vitro 3D Platforms for More
Physiologically Relevant Modeling
Stem Cells Exude Great Potential in Drug Toxicity Testing
Global Market for Stem Cell-Assays
Functional Assays: An Effective Way of Predicting Specific
Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
Molecular Imaging and ADME
Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology
Testing
Technological Advancements in ADME Toxicology Testing

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Cell
Culture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Cell Culture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for High
Throughput Screening by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for High Throughput Screening by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for High Throughput
Screening by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 7: World Recent Past, Current & Future Analysis for
Molecular Imaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Molecular Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Molecular Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
OMICS by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 11: World Historic Review for OMICS by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for OMICS by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Cellular Assay by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Cellular Assay by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Cellular Assay by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Biochemical Assay by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Biochemical Assay by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Biochemical Assay by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Ex-Vivo by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Ex-Vivo by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Ex-Vivo by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for In
Silica by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for In Silica by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for In Silica by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Systemic Toxicity by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Systemic Toxicity by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Systemic Toxicity by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Renal Toxicity by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Renal Toxicity by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 33: World 16-Year Perspective for Renal Toxicity by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Hepatotoxicity by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Hepatotoxicity by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 36: World 16-Year Perspective for Hepatotoxicity by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Neurotoxicity by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 38: World Historic Review for Neurotoxicity by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 39: World 16-Year Perspective for Neurotoxicity by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 40: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 41: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 42: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 43: World ADME-Toxicology Testing Market Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2030

Table 44: World Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 45: World Historic Review for ADME-Toxicology Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 46: World 16-Year Perspective for ADME-Toxicology Testing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 47: USA Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 48: USA Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 49: USA 16-Year Perspective for ADME-Toxicology Testing
by Technology - Percentage Breakdown of Value Sales for Cell
Culture, High Throughput Screening, Molecular Imaging, OMICS
and Other Technologies for the Years 2014, 2023 & 2030

Table 50: USA Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 51: USA Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 52: USA 16-Year Perspective for ADME-Toxicology Testing
by Method - Percentage Breakdown of Value Sales for Cellular
Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years
2014, 2023 & 2030

Table 53: USA Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 54: USA Historic Review for ADME-Toxicology Testing by
Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 55: USA 16-Year Perspective for ADME-Toxicology Testing
by Application - Percentage Breakdown of Value Sales for
Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity and Other Applications for the Years 2014, 2023 &
2030

CANADA
Table 56: Canada Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 58: Canada 16-Year Perspective for ADME-Toxicology
Testing by Technology - Percentage Breakdown of Value Sales for
Cell Culture, High Throughput Screening, Molecular Imaging,
OMICS and Other Technologies for the Years 2014, 2023 & 2030

Table 59: Canada Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 60: Canada Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 61: Canada 16-Year Perspective for ADME-Toxicology
Testing by Method - Percentage Breakdown of Value Sales for
Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for
the Years 2014, 2023 & 2030

Table 62: Canada Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 63: Canada Historic Review for ADME-Toxicology Testing by
Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 64: Canada 16-Year Perspective for ADME-Toxicology
Testing by Application - Percentage Breakdown of Value Sales
for Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity and Other Applications for the Years 2014, 2023 &
2030

JAPAN
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 65: Japan Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 67: Japan 16-Year Perspective for ADME-Toxicology Testing
by Technology - Percentage Breakdown of Value Sales for Cell
Culture, High Throughput Screening, Molecular Imaging, OMICS
and Other Technologies for the Years 2014, 2023 & 2030

Table 68: Japan Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 69: Japan Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 70: Japan 16-Year Perspective for ADME-Toxicology Testing
by Method - Percentage Breakdown of Value Sales for Cellular
Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years
2014, 2023 & 2030

Table 71: Japan Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 72: Japan Historic Review for ADME-Toxicology Testing by
Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 73: Japan 16-Year Perspective for ADME-Toxicology Testing
by Application - Percentage Breakdown of Value Sales for
Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity and Other Applications for the Years 2014, 2023 &
2030

CHINA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 74: China Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 75: China Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 76: China 16-Year Perspective for ADME-Toxicology Testing
by Technology - Percentage Breakdown of Value Sales for Cell
Culture, High Throughput Screening, Molecular Imaging, OMICS
and Other Technologies for the Years 2014, 2023 & 2030

Table 77: China Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 78: China Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 79: China 16-Year Perspective for ADME-Toxicology Testing
by Method - Percentage Breakdown of Value Sales for Cellular
Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years
2014, 2023 & 2030

Table 80: China Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 81: China Historic Review for ADME-Toxicology Testing by
Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 82: China 16-Year Perspective for ADME-Toxicology Testing
by Application - Percentage Breakdown of Value Sales for
Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity and Other Applications for the Years 2014, 2023 &
2030

EUROPE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 83: Europe Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 84: Europe Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 85: Europe 16-Year Perspective for ADME-Toxicology
Testing by Technology - Percentage Breakdown of Value Sales for
Cell Culture, High Throughput Screening, Molecular Imaging,
OMICS and Other Technologies for the Years 2014, 2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 87: Europe Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 88: Europe 16-Year Perspective for ADME-Toxicology
Testing by Method - Percentage Breakdown of Value Sales for
Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for
the Years 2014, 2023 & 2030

Table 89: Europe Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 90: Europe Historic Review for ADME-Toxicology Testing by
Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 91: Europe 16-Year Perspective for ADME-Toxicology
Testing by Application - Percentage Breakdown of Value Sales
for Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity and Other Applications for the Years 2014, 2023 &
2030

Table 92: Europe Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 93: Europe Historic Review for ADME-Toxicology Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 94: Europe 16-Year Perspective for ADME-Toxicology
Testing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2014, 2023 & 2030

FRANCE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 95: France Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Technology - Cell Culture, High
Throughput Screening, Molecular Imaging, OMICS and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 96: France Historic Review for ADME-Toxicology Testing by
Technology - Cell Culture, High Throughput Screening, Molecular
Imaging, OMICS and Other Technologies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 97: France 16-Year Perspective for ADME-Toxicology
Testing by Technology - Percentage Breakdown of Value Sales for
Cell Culture, High Throughput Screening, Molecular Imaging,
OMICS and Other Technologies for the Years 2014, 2023 & 2030

Table 98: France Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Method - Cellular Assay, Biochemical
Assay, Ex-Vivo and In Silica - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 99: France Historic Review for ADME-Toxicology Testing by
Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In
Silica Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 100: France 16-Year Perspective for ADME-Toxicology
Testing by Method - Percentage Breakdown of Value Sales for
Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for
the Years 2014, 2023 & 2030

Table 101: France Recent Past, Current & Future Analysis for
ADME-Toxicology Testing by Application - Systemic Toxicity,
Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 102: France Historic Review for ADME-Toxicology Testing
by Application - Systemic Toxicity, Renal Toxicity,
Hepatotoxicity, Neurotoxicity and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 103: France 16-Year Perspective for ADME-Toxicology
Testing by Application - Percentage Breakdown of Value Sales
for Systemic Toxicity, Renal Toxicity, Hepatotoxicity,

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.